Vérification…
Traduit automatiquement. Doses et mises en garde : vérifiez l'original en anglais. Lire en anglais
Accueil / Enregistré au Nigeria / Krystapen Injection 1 Mega_

Krystapen Injection 1 Mega_

NAFDAC REG NO: A4-101241 Médicament

Enregistré auprès de NAFDAC. Enregistrement actifAs of 3 November 2026 · synced automatically from official sources.
Produit
Krystapen Injection 1 Mega_
Numéro NAFDAC
A4-101241
Principe actif
Benzylpenicillin sodium
Dosage
600 mg
Forme
Powder for injection
Conditionnement
1 x 10's (in vials)
Fabricant
Non répertorié
Déposant / Titulaire :
Grace Pharmacare Ltd
Approuvé
30 Apr 2025
Statut
Actif Vue sur NAFDAC ↗
Enregistrement valable jusqu'au
29 Apr 2030
Alertes OMS
Non trouvé
Community reports
None
Times checked
0

What we found

  • Krystapen Injection 1 Mega_ is on the NAFDAC register with an active registration (A4-101241). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.

How to use Krystapen Injection 1 Mega_

Ce que dit la notice officielle. Si un médecin vous l'a prescrit, suivez l'ordonnance. La notice de votre boîte prime si elle est différente.

Pour qui

Therapy Penicillin G Potassium Injection, USP is indicated in the treatment of serious infections caused by susceptible strains of the designated microorganisms in the conditions listed below. Appropriate culture and susceptibility tests should be done before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to penicillin G. Therapy with Penicillin G Potassium Injection, USP may be initiated before results of such tests are known when there is reason to believe the infection may involve any of the organisms listed below; however, once these results become available, appropriate therapy should be continued. …

Comment le prendre et à quelle fréquence
  • Penicillin G Potassium Injection, USP should be administered by intravenous infusion
  • The usual dose recommendations are as follows: Adult patients (*) Because of its short half-life, Penicillin G is administered in divided doses, usually every 4-6 hours with the exception of meningococcal meningitis/septicemia, i.e. , every 2 hours
  • CLINICAL INDICATION DOSAGE Serious infections due to susceptible strains of streptococci (including S. pneumoniae ) -septicemia, empyema, pneumonia, pericarditis, endocarditis and meningitis 12 to 24 million units/day depending on the infection and its severity administered in equally divided doses every 4-6 hours
  • Serious infections due to susceptible strains of staphylococci - septicemia, empyema, pneumonia, pericarditis, endocarditis and meningitis 5 to 24 million units/day depending on the infection and its severity administered in equally divided doses every 4-6 hours
  • Anthrax Minimum of 8 million units/day in divided doses every 6 hours
  • Higher doses may be required depending on susceptibility of organism. …
Children
  • Incompletely developed renal function in newborns may delay elimination of penicillin; therefore, appropriate reductions in the dosage and frequency of administration should be made in these patients
  • All newborns treated with penicillins should be monitored closely for clinical and laboratory evidence of toxic or adverse effects (see PRECAUTIONS )
  • Pediatric doses are generally determined on a weight basis and should be calculated for each patient individually
  • Recommended guidelines for pediatric dosages are presented in Dosage and Administration . …
Older adults

Clinical studies of Penicillin G Injection did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger patients. …

While you are taking it
  • Patients should be counseled that antibacterial drugs including Penicillin G Potassium Injection, USP should only be used to treat bacterial infections
  • They do not treat viral infections (e.g., the common cold)
  • When Penicillin G Potassium Injection, USP is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. …
Talk to a doctor first if
  • A history of a hypersensitivity (anaphylactic) reaction to any penicillin is a contraindication
  • Solutions containing dextrose may be contraindicated in patients with known allergy to corn or corn products
Medicines it may not mix with

Bacteriostatic antibacterials ( i.e. , chloramphenicol, erythromycins, sulfonamides or tetracyclines) may antagonize the bactericidal effect of penicillin, and concurrent use of these drugs should be avoided. This has been documented in vitro ; however, the clinical significance of this interaction is not well-documented. Penicillin blood levels may be prolonged by concurrent administration of probenecid which blocks the renal tubular secretion of penicillins. Other drugs may compete with penicillin G for renal tubular secretion and thus prolong the serum half-life of penicillin. …

Warnings

Serious and occasionally fatal hypersensitivity (anaphylactic) reactions have been reported in patients on penicillin therapy. These reactions are more likely to occur in individuals with a history of penicillin hypersensitivity and/or a history of sensitivity to multiple allergens. There have been reports of individuals with a history of penicillin hypersensitivity who have experienced severe reactions when treated with cephalosporins. Before initiating therapy with penicillin G, careful inquiry should be made concerning previous hypersensitivity reactions to penicillins, cephalosporins, or other allergens. …

Effets secondaires possibles

Body as a whole: The Jarisch-Herxheimer reaction is a systemic reaction, that may occur after the initiation of penicillin therapy in patients with syphilis or other spirochetal infections ( i.e. , Lyme disease and Relapsing fever). The reaction begins one to two hours after initiation of therapy and disappears within 12 to 24 hours. It is characterized by fever, chills, myalgias, headache, exacerbation of cutaneous lesions, tachycardia, hyperventilation, vasodilation with flushing and mild hypotension. The pathogenesis of the Herxheimer reaction may be due to the release from the spirochetes of heat-stable pyrogen. …

Pregnancy and breastfeeding

Pregnancy Reproduction studies performed in the mouse, rat and rabbit have revealed no evidence of impaired fertility or harm to the fetus due to penicillin G. Human experience with the penicillins during pregnancy has not shown any positive evidence of adverse effects on the fetus. There are, however, no adequate and well controlled studies in pregnant women showing conclusively that harmful effects of these drugs on the fetus can be excluded. …

If you take too much

Dose related toxicity may arise with the use of massive doses of intravenous penicillins (40 to 100 million units per day), particularly in patients with severe renal impairment (see PRECAUTIONS ). The manifestations may include agitation, confusion, asterixis, hallucinations, stupor, coma, multifocal myoclonus, seizures and encephalopathy. Hyperkalemia is also possible (see ADVERSE REACTIONS -Metabolic). In case of overdosage, discontinue penicillin, treat symptomatically and institute supportive measures as required. …

En cas d'oubli

Prenez-le dès que vous y pensez, sauf s'il est presque l'heure de la dose suivante. Dans ce cas, sautez la dose oubliée. Ne prenez jamais deux doses à la fois pour compenser. Vérifiez votre notice, certains médicaments font exception.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2026-07-24.

Label for benzylpenicillin sodium, the active ingredient registered with NAFDAC.

Check your pack of Krystapen Injection 1 Mega_

Add the expiry date on your pack for a full Trust Score.

Ou prenez la boîte en photo
Encore 3 vérifications gratuites aujourd'hui Official sources: U.S. FDA · EMA (EU) · Health Canada · WHO alerts

About Krystapen Injection 1 Mega_

What is in Krystapen Injection 1 Mega_?

Krystapen Injection 1 Mega_ contains Benzylpenicillin sodium (600 mg), as powder for injection, according to its NAFDAC registration record.

Is Krystapen Injection 1 Mega_ registered with NAFDAC?

Yes. Krystapen Injection 1 Mega_ is listed on the NAFDAC register under registration number A4-101241, and its registration is active as of 3 November 2026.

Has Krystapen Injection 1 Mega_ been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Krystapen Injection 1 Mega_ in our automatically synced alert list.

How can I check that my pack of Krystapen Injection 1 Mega_ is genuine?

Run a free authenticity scan with the NAFDAC number A4-101241, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

How do I take Krystapen Injection 1 Mega_?

Follow your prescription or the leaflet in your pack. The official label says: Penicillin G Potassium Injection, USP should be administered by intravenous infusion. The usual dose recommendations are as follows: Adult patients (*) Because of its short half-life, Penicillin G is administered in divided doses, usually every 4-6 hours with the exception of meningococcal meningitis/septicemia, i.e. , every 2 hours. CLINICAL INDICATION DOSAGE Serious infection…

What is Krystapen Injection 1 Mega_ used for?

Therapy Penicillin G Potassium Injection, USP is indicated in the treatment of serious infections caused by susceptible strains of the designated microorganisms in the conditions listed below. Appropriate culture and susceptibility tests should be done before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to penicillin G. Therapy with P (Summarised from the official U.S. FDA label for benzylpenicillin sodium. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Krystapen Injection 1 Mega_? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.